Services

Background

Nomura Code - the specialists in life sciences

Nomura Code is recognised as Europe’s leading investment bank focused on life sciences and provides a full range of advisory, fundraising and broking services. The team at Nomura Code is the longest established and most experienced in the sector, having executed over 130 life sciences transactions, including 36 IPOs, 48 secondary offerings and 14 private placings which have raised over €3.5 billion. Nomura Code offers a dedicated healthcare team with the support, international reach and financial capabilities of the Nomura Group, a leading global investment bank.

Nomura Code is a recognised leader in the life sciences sector and offers:
  • a dedicated entrepreneurial team with the support, experience and financial capabilities of the Nomura Group, a leading global investment bank;
  • the strongest sector-specific research and sales team with seven analysts, five sales people and four sales traders;
  • the most experienced industry-focused corporate finance team; and
  • commitment at all levels to its clients’ needs.
In 2005, Nomura Code expanded its remit to provide specialist investment banking for the environmental sciences sector. Nomura Code has been the most active adviser on biotech and medical technology financings in Europe since 2004, having advised on:
  • eleven IPOs - Main Market, AIM and Euronext
  • one in five life sciences fundraisings
  • the raising of over €600 million
In 2006, Nomura Code advised on many transactions including:
  1. £50m IPO of Optos on the Main Market of the London Stock Exchange
  2. £50m IPO of Renovo on the Main Market of the London Stock Exchange
  3. £10m IPO of Powerfilm on the AIM of the London Stock Exchange
  4. £12m IPO of Napo Pharmaceuticals on the Main Market of the London Stock Exchange
  5. £30m IPO of PuriCore on the Main Market of the London Stock Exchange
  6. £20m acquisition of Serotec by Morphosys
  7. £45m sale of Healthcare division by Perlos
  8. £38m Placing and Open Offer for Protherics
  9. £7.7m Placing for Biofusion
In 2007, Nomura Code has advised on several transactions including:
  1. £15m Placing for XCounter
  2. £20m Placing for AgCert
Nomura Code advises on a range of transactions including mergers and acquisitions, secondary offerings, private placings and IPOs.
Page Top